IL6 and cancer: IL6-associated pathways (e.g., focal adhesion, cytoskeleton regulation) were enriched (GeneRatio = 0.03–0.05), with miR-146a-5p targeting genes in endocytosis and proteoglycans in cancer, suggesting roles in immune dysregulation and implantation failure.